HKD 2.74
(-1.08%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 20.33 Billion | 25.91 Billion | 44.57 Billion | 39.16 Billion | 27.82 Billion |
Net Income | 5.77 Billion | 4.8 Billion | 5.72 Billion | 6.41 Billion | 5.08 Billion |
Depreciation & Amortization | 1.7 Billion | 1.66 Billion | 1.74 Billion | 1.6 Billion | 1.56 Billion |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 16.46 Billion | 37.87 Billion | 54.79 Billion | 49.32 Billion | 34.63 Billion |
Other non-cash items | -6.29 Billion | -13.57 Billion | -12.32 Billion | -11.66 Billion | -13.45 Billion |
Investing Cash Flow | -36.41 Billion | -28.41 Billion | -4.68 Billion | -55.96 Billion | -15.8 Billion |
Investments in PPE | -2.05 Billion | -1.43 Billion | -1.69 Billion | -2.36 Billion | -1.64 Billion |
Acquisitions | - | - | - | - | - |
Investment purchases | -274.47 Billion | -278.45 Billion | -201.07 Billion | -236.74 Billion | - |
Sales/Maturities of investments | 228.18 Billion | 238.03 Billion | 185.93 Billion | 169 Billion | - |
Other Investing Activities | -379 Million | -340 Million | 52 Million | -104 Million | -14.15 Billion |
Financing Cash Flow | 18.12 Billion | 1.87 Billion | -26.36 Billion | 17.45 Billion | -9.84 Billion |
Debt repayment | -7 Billion | -1 Billion | -3.57 Billion | -476 Million | -5.31 Billion |
Dividends payments | -2.02 Billion | -1.7 Billion | -1.51 Billion | -391 Million | -759 Million |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | 5.77 Billion | - | - | - |
Other Financing Activities | 14.33 Billion | 239 Million | -19.97 Billion | 19.4 Billion | -3.77 Billion |
Accounts receivables | - | 664 Million | -1.29 Billion | 529 Million | -4.06 Billion |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | 16.46 Billion | 37.83 Billion | 56.08 Billion | 48.79 Billion | 38.69 Billion |
Cash at beginning of period | 24.83 Billion | 25.28 Billion | 11.82 Billion | 11.24 Billion | 9.05 Billion |
Cash at end of period | 26.69 Billion | 24.83 Billion | 25.28 Billion | 11.82 Billion | 11.24 Billion |
Capital Expenditure | -2.05 Billion | -1.43 Billion | -1.69 Billion | -2.36 Billion | -1.64 Billion |
Effect of forex changes on cash | -184 Million | 171 Million | -64 Million | -75 Million | 5 Million |
Net cash flow / Change in cash | 1.86 Billion | -452 Million | 13.46 Billion | 577 Million | 2.19 Billion |
Free Cash Flow | 18.28 Billion | 24.48 Billion | 42.87 Billion | 36.79 Billion | 26.18 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.57 Billion | 1.57 Billion | 421.5 Million | 5.77 Billion | 421.5 Million | 1.44 Billion |
Depreciation & Amortization | 316 Million | 316 Million | 824.5 Million | 1.7 Billion | 824.5 Million | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | 16.46 Billion | - | - |
Other non-cash items | 8.28 Billion | 8.28 Billion | 1 Billion | -6.29 Billion | 1 Billion | 6.46 Billion |
Investing Cash Flow | -12.44 Billion | -12.44 Billion | -2.07 Billion | -36.41 Billion | -2.07 Billion | -16.12 Billion |
Investments in PPE | -130 Million | -130 Million | -214.5 Million | -2.05 Billion | -214.5 Million | -811 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | -274.47 Billion | - | - |
Sales/Maturities of investments | - | - | - | 228.18 Billion | - | - |
Other Investing Activities | -12.31 Billion | -12.31 Billion | -1.86 Billion | -379 Million | -1.86 Billion | -15.31 Billion |
Financing Cash Flow | -3.85 Billion | -3.85 Billion | 3.04 Billion | 18.12 Billion | 3.04 Billion | 6.02 Billion |
Debt repayment | - | - | - | -7 Billion | - | - |
Dividends payments | - | - | -1.01 Billion | -2.02 Billion | -1.01 Billion | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -3.85 Billion | -3.85 Billion | 4.05 Billion | 14.33 Billion | 4.05 Billion | 6.02 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | 24.83 Billion | - | - |
Cash at end of period | -6.11 Billion | -6.11 Billion | 3.23 Billion | 26.69 Billion | 3.23 Billion | -2.3 Billion |
Capital Expenditure | -130 Million | -130 Million | -214.5 Million | -2.05 Billion | -214.5 Million | -811 Million |
Effect of forex changes on cash | 4 Million | 4 Million | 13 Million | -184 Million | 13 Million | -105 Million |
Net cash flow / Change in cash | -6.11 Billion | -6.11 Billion | 3.23 Billion | 1.86 Billion | 3.23 Billion | -2.3 Billion |
Free Cash Flow | 10.04 Billion | 10.04 Billion | 2.04 Billion | 18.28 Billion | 2.04 Billion | 7.1 Billion |
HYEG
IFX
MEQ
BIOT
603188
GGRGF